20 June 2013
Keywords: abraxis, seeks, reacquire, abraxane, marketing, rights, az
Article | 01 December 2008
USA-based Abraxis BioScience has entered into an agreement with Anglo-Swedish drug major AstraZeneca, under which, subject to
approval by the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 December 2008
19 June 2013
© 2013 thepharmaletter.com